March 13, 2026
Headlines

Where Teva Pharmaceutical Indus Stands With Analysts

Sumain Faisal01 mins

Latest Ratings for TEVA

Date Firm Action From To
Feb 2022 Barclays Maintains Equal-Weight
Jan 2022 Argus Research Downgrades Buy Hold
Oct 2021 Raymond James Downgrades Outperform Market Perform

View More Analyst Ratings for TEVA

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News